Prime Medicine (PRME) Leases: 2021-2025
Historic Leases for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $117.9 million.
- Prime Medicine's Leases rose 138.78% to $117.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.9 million, marking a year-over-year increase of 138.78%. This contributed to the annual value of $47.2 million for FY2024, which is 238.25% up from last year.
- As of Q3 2025, Prime Medicine's Leases stood at $117.9 million, which was down 1.94% from $120.2 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Leases ranged from a high of $120.2 million in Q2 2025 and a low of $10.7 million during Q4 2021.
- For the 3-year period, Prime Medicine's Leases averaged around $53.2 million, with its median value being $44.9 million (2024).
- As far as peak fluctuations go, Prime Medicine's Leases tumbled by 52.81% in 2023, and later soared by 238.25% in 2024.
- Quarterly analysis of 5 years shows Prime Medicine's Leases stood at $10.7 million in 2021, then surged by 174.94% to $29.5 million in 2022, then crashed by 52.81% to $13.9 million in 2023, then spiked by 238.25% to $47.2 million in 2024, then surged by 138.78% to $117.9 million in 2025.
- Its Leases stands at $117.9 million for Q3 2025, versus $120.2 million for Q2 2025 and $76.8 million for Q1 2025.